A recent metanalysis detected that patients taking GLP-1 RA had a prolonged T 1/2 (the time required for 50% of ingested gastric contents to leave the stomach) of 138 min (confidence interval [CI] 74202 min) vs 95 min (CI 55135 min) in the placebo group, with a pooled mean difference of 36 min ( P 4 h for clear liquids with 10% carbohydrate content in patients taking GLP-1 RAs, we recommend a fasting duration of 8 h for high-calorie liquids
Obesity is recognised as a risk factor for developing diverticulitis and experiencing more severe complications, according to NHS guidance
Proc Natl Acad Sci United States America (2001) 98(18):101027
He S, Kahles F, Rattik S, Nairz M, McAlpine CS, Anzai A, et al
Foundayo (orforglipron) , a new oral GLP-1, received FDA approval on April 1, 2026